Prosecution Insights
Prosecution Insights
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| §102 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAUK TEODORO, PRICILA NMN | 1 | 100.0% | +0.0% |
| MORGAN, BAILEY MICHELLE | 1 | 57.1% | +56.3% |
| ZEMAN, ROBERT A | 1 | 54.0% | +27.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18252048 | MYCOBACTERIAL IMMUNOTHERAPY FOR TREATING CANCER | HAUK TEODORO, PRICILA NMN | 53d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17904155 | PREVENTION AND TREATMENT OF INFECTIONS INCLUDING THOSE CAUSED BY CORONAVIRUS | MORGAN, BAILEY MICHELLE | 30d overdue |
| 17758139 | IMMUNOTHERAPEUTIC TREATMENT OF CANCER | ZEMAN, ROBERT A | 29d overdue |
| Art Unit | Apps |
|---|---|
| 1645 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18252048 | MYCOBACTERIAL IMMUNOTHERAPY FOR TREATING CANCER | HAUK TEODORO, PRICILA NMN | 1645 | §103 | Non-Final OA | 53d overdue | Pending | May 08, 2023 |
| 17904155 | PREVENTION AND TREATMENT OF INFECTIONS INCLUDING THOSE CAUSED BY CORONAVIRUS | MORGAN, BAILEY MICHELLE | 1645 | §102 | Final Rejection | 30d overdue | Pending | Aug 12, 2022 |
| 17758139 | IMMUNOTHERAPEUTIC TREATMENT OF CANCER | ZEMAN, ROBERT A | 1645 | §103 | Final Rejection | 29d overdue | Pending | Jun 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial